State of the Market: Early Detection Testing for Alzheimer’s Disease
Screening for early, subtle signs of Alzheimer’s disease becomes important as pharmaceutical companies shift focus to drug candidates that may prevent or slow buildup of amyloid beta protein in the…
(PRWeb November 13, 2012)
Read the full story at http://www.prweb.com/releases/2012/11/prweb10054966.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.